Short Interest in Laboratorios Farmaceuticos Rovi, S.A. (OTCMKTS:LABFF) Increases By 59.8%

Laboratorios Farmaceuticos Rovi, S.A. (OTCMKTS:LABFF) was the target of a significant increase in short interest during the month of August. As of August 15th, there was short interest totaling 19,500 shares, anincreaseof59.8% from the July 31st total of 12,200 shares. Based on an average daily volume of 0 shares, the short-interest ratio is presently ∞ days. Based on an average daily volume of 0 shares, the short-interest ratio is presently ∞ days.

Laboratorios Farmaceuticos Rovi Price Performance

Shares of OTCMKTS LABFF opened at C$65.86 on Friday. The business has a fifty day simple moving average of C$65.86 and a 200-day simple moving average of C$65.86. Laboratorios Farmaceuticos Rovi has a 12 month low of C$65.86 and a 12 month high of C$65.86.

About Laboratorios Farmaceuticos Rovi

Laboratorios Farmaceuticos Rovi, SA engages in the research, development, manufacture, and marketing of pharmaceutical products in Spain and internationally. The company provides products for cardiology, osteoarticular/women's health, anesthesia /pain, diagnostic imaging contrast agents, central nervous system, urology, endocrinology, respiratory, and primary healthcare areas.